UK markets close in 3 hours 58 minutes

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.97-0.41 (-1.83%)
At close: 04:00PM EDT
21.97 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-240,634
-209,360
-149,338
24,926
-73,158
Depreciation & amortisation
12
12
33
43
89
Stock-based compensation
33,612
30,951
16,019
13,317
9,057
Change in working capital
15,873
31,860
1,656
-9,597
-7,934
Accounts payable
752
5,611
-1,319
2,161
-2,670
Other working capital
-204,921
-160,601
-133,675
29,002
-71,260
Other non-cash items
873
739
1,524
187
816
Net cash provided by operating activities
-204,921
-160,601
-133,675
29,131
-71,260
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-129
-
Purchases of investments
-460,406
-354,606
-495,346
-294,719
-278,937
Sales/maturities of investments
458,701
472,215
308,933
253,975
136,407
Net cash used for investing activities
-1,705
117,609
-186,188
-40,873
-142,530
Cash flows from financing activities
Debt repayment
-
0
-20,996
0
0
Common stock issued
-
258,094
181,390
86,337
278,060
Other financing activities
-
-
-
576
1
Net cash used provided by (used for) financing activities
263,826
264,132
172,254
118,464
304,424
Net change in cash
57,200
221,140
-147,609
106,722
90,634
Cash at beginning of period
57,632
74,471
222,080
115,358
24,724
Cash at end of period
114,832
295,611
74,471
222,080
115,358
Free cash flow
Operating cash flow
-204,921
-160,601
-133,675
29,131
-71,260
Capital expenditure
-
-
-
-129
-
Free cash flow
-204,921
-160,601
-133,675
29,002
-71,260